Passumpsic Savings Bank’s Pfizer PFE Stock Holding History

Passumpsic Savings Bank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$618K	Buy	+24,827	New	+$626K	0.34%	62
2024 Q4	$655K	Sell	24,689 -991	-4%	-$26.9K	0.41%	56
2024 Q3	$743K	Buy	25,680 +1,998	+8%	+$58.3K	0.49%	51
2024 Q2	$663K	Sell	23,682 -732	-3%	-$20.2K	0.48%	50
2024 Q1	$677K	Buy	+24,414	New	+$677K	0.43%	54

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Passumpsic Savings Bank's PFE Position: Q4 2025 in Review

Passumpsic Savings Bank opened a new position in Pfizer (PFE) in Q4 2025: 24,827 shares worth $618K. The stake represents 0.34% of the portfolio and ranks #62 among its holdings. This is a return to the name: Passumpsic Savings Bank previously reported a position in PFE as recently as Q4 2024.

Passumpsic Savings Bank first reported a position in PFE in Q1 2024 and has held it in 5 quarters since. The position peaked at $743K in Q3 2024. 2,912 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Passumpsic Savings Bank held 24,827 shares of Pfizer worth $618K as of Q4 2025.
Pfizer was a new Passumpsic Savings Bank position in Q4 2025.
Pfizer made up 0.34% of Passumpsic Savings Bank's portfolio in Q4 2025, its #62 holding.
Passumpsic Savings Bank first reported a position in Pfizer in Q1 2024 and has held it in 5 quarters since.
Passumpsic Savings Bank's Pfizer position peaked at $743K in Q3 2024.
2,912 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Passumpsic Savings Bank's 13F filing for Q4 2025, filed 5 Feb 2026.